Aethlon Medical, Inc.AEMDNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank85
5Y CAGR-16.8%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
-16.8%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 29.29% |
| Q3 2025 | -99.91% |
| Q2 2025 | 204625.25% |
| Q1 2025 | -67.39% |
| Q4 2024 | -37.47% |
| Q3 2024 | 10.73% |
| Q2 2024 | -21.97% |
| Q1 2024 | 24.66% |
| Q4 2023 | -15.15% |
| Q3 2023 | -6.83% |
| Q2 2023 | 11.66% |
| Q1 2023 | 7.10% |
| Q4 2022 | -22.25% |
| Q3 2022 | 26.13% |
| Q2 2022 | -23.50% |
| Q1 2022 | 49.26% |
| Q4 2021 | 18.89% |
| Q3 2021 | -4.02% |
| Q2 2021 | -2.98% |
| Q1 2021 | -25.10% |
| Q4 2020 | 73.27% |
| Q3 2020 | 25.59% |
| Q2 2020 | -29.19% |
| Q1 2020 | 54.43% |
| Q4 2019 | -24.22% |
| Q3 2019 | 6.65% |
| Q2 2019 | -4.48% |
| Q1 2019 | -14.92% |
| Q4 2018 | 45.80% |
| Q3 2018 | 8.02% |
| Q2 2018 | -7.35% |
| Q1 2018 | 8.68% |
| Q4 2017 | 0.18% |
| Q3 2017 | 6.57% |
| Q2 2017 | -22.87% |
| Q1 2017 | 21.73% |
| Q4 2016 | -52.73% |
| Q3 2016 | 130.11% |
| Q2 2016 | -12.01% |
| Q1 2016 | -6.79% |